CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Omthera Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Omthera Pharmaceuticals/AstraZeneca | Omthera Pharmaceuticals, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Sep 1, 2013

Acquired by AstraZeneca on May 1, 2013

Timeline

2000s

Jun 1, 2008
Omthera Pharmaceuticals— Founded

2010s

May 1, 2013
AstraZeneca— Acquired By
May 5, 2014
omega-3-carboxylic acids— NDA Organization

Drugs by trial phase (7 distinct, 5 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

omega-3-carboxylic acids

Recent trials (6)

NCT02859129Study directorPhase 1Sep 1, 2013
NCT01486433Study directorPhase 1Nov 1, 2011
NCT01431690Study directorPhase 1Aug 1, 2011
NCT01408303Study directorPhase 3Aug 1, 2011
NCT01408303CollaboratorPhase 3Aug 1, 2011
NCT01242527Study directorPhase 2/Phase 3Jan 1, 2011

Details

Founded: Princeton, NJ, US Jun 1, 2008
First NDA: May 5, 2014
Last known activity: Sep 1, 2013